Malpractice Cases Fewer, Communication Still Key
Although 40 percent of surveyed mammographers anticipate a suit in the next five years, in reality 10 percent will face a legal challenge.
Patients are bringing fewer malpractice cases, according to a malpractice update presentation held Tuesday at the American Roentgen Ray Society (ARRS) annual meeting.
If you are going to get sued, it's most likley to be related to failure to diagnose lung or breast cancer, according to Leonard Berlin, MD, vice chair of radiology at NorthShore University Health System in Chicago.
Guilty verdicts are most common in birth injury and breast cancer suits at about 50 percent, said Berlin.
Still, it's important not to get paranoid. Only 10 percent of mammogrpahers will face a claim in the next five years, but 40 percent of those surveyed expect one, according to Berlin.
Berlin's main point was that radiologists who communicate well are sued less often, regardless of technical skill. (For more complete coverage of his talk, see this article from CMIO.)
That has been clear for years.
For advice on avoiding claims, peruse this article, with details straight from plantiff attorneys:
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
